Special Populations, Frailty, Sex/Pregnancy-Relevant Interfaces, and Equity Considerations

70.1Special-population factors change the decision in front of you

The first question is not whether the patient belongs to a special population. The first question is which vascular decision changes because the patient does not match the default template. A bypass, endovascular intervention, amputation, aortic surveillance plan, wound-care schedule, or discharge plan is often imagined for a patient with stable baseline function, predictable physiologic reserve, reliable transport, affordable medication, and the ability to return when symptoms change. When those assumptions are false, the clinical decision itself has changed. Frailty modifies operative burden and recovery planning; sex and gender modify PAD recognition and treatment quality; pregnancy and aortopathy modify timing, imaging, medication, delivery, and postpartum planning; structural determinants modify whether follow-up, wound care, and secondary prevention are deliverable AHA 2023 · Frailty score outcomes 2023 · Association Frailty Failure 2018 · PAD 2022.

The useful habit is to name the exact link between the modifier and the decision. Frailty is not a label of old age; it is reduced reserve that changes the balance between procedural stress, complication tolerance, discharge destination, and the support required for recovery Frailty score outcomes 2023 · Association Frailty Failure 2018. Sex and gender context in PAD changes the diagnostic doorway: the patient may present through walking limitation, reduced pace, tissue loss, diabetes-related foot risk, or atypical exertional symptoms rather than the classical calf-pain vignette PAD 2024 · PAD 2022. Pregnancy-relevant vascular disease changes the arc of care; counseling, medication review, imaging, delivery planning, and postpartum vigilance belong before the emergency rather than after it AHA 2022 · ESC 2018 · Obstetric considerations aortopathy 2023. Structural determinants change which plan is real: a wound pathway, antithrombotic prescription, exercise recommendation, or surveillance schedule that the patient cannot access is not yet treatment AHA 2023 · PAD 2026 · Social Structural Determinants 2025.

This framing prevents two common errors. One error is to treat the modifier as a decorative descriptor: frail, female, pregnant, socially complex, then proceed as if the operative plan is unchanged. The opposite error is to let the descriptor substitute for clinical reasoning: frail means no intervention, female means a separate aortic threshold, poor access means poor adherence, pregnancy means all vascular decisions are deferred. Neither approach is safe. The modifier should force a more precise decision: smaller or staged operation, different surveillance setting, objective PAD testing despite a non-classical story, planned maternal-aortic care, or a discharge plan that names transport, wound-care route, medication access, and return precautions.

For a frail patient with limb-threatening ischemia, the operative note should not merely say that frailty was present. It should state whether the chosen strategy is intended to preserve walking, control pain, treat infection, prevent limb loss, or permit discharge, and what recovery support makes that goal plausible. For a woman with exertional limitation and weak pulses, the clinic letter should not dismiss PAD because the pain is not a textbook calf cramp. It should record function, pulses, wound status, risk burden, and the planned objective assessment. For a patient with aortopathy who may become pregnant, the plan should identify the pre-pregnancy counseling, imaging, medication, delivery, and postpartum elements. For a patient whose wound-care access is fragile, the discharge plan should specify who will see the wound, when, how the patient will get there, and how deterioration will trigger vascular reassessment.

The practical endpoint is a vascular plan that exposes its assumptions. If the operation depends on rehabilitation, the plan names rehabilitation. If limb salvage depends on wound care, the plan names wound care. If PAD diagnosis depends on testing, the plan arranges testing rather than hoping the patient returns. If aortic safety depends on pregnancy timing and postpartum surveillance, the plan names the responsible team and route back to care. Special-population reasoning is not a separate chapter in the patient’s care; it is the part of ordinary vascular surgery that asks whether the default pathway still fits.

70.2Frailty informs proportionality, not denial

Frailty should enter the vascular consultation before the patient reaches the operating room, because it changes the expected cost of the same technical act. It describes impaired physiologic and functional reserve rather than chronological age alone. Across vascular surgery and amputation populations, frailty is associated with worse postoperative outcomes; in vascular registry work, frailty has also been linked to failure-to-rescue after major complications, which is exactly the problem a surgeon is trying to anticipate when choosing between surveillance, endovascular repair, open surgery, staged limb salvage, or amputation Frailty score outcomes 2023 · Association Frailty Failure 2018. The conclusion is not that frail patients should be denied intervention. The conclusion is that the intervention must be proportionate to the patient’s reserve, goals, complication tolerance, and recovery pathway.

Tool choice matters because frailty measures do not all answer the same clinical question. Some instruments emphasize comorbidity and disability; others emphasize mobility, cognition, nutrition, or functional dependence. A score that helps frame elective aneurysm repair may not be the right gate for dialysis access, urgent revascularization, chronic limb-threatening ischemia, or major amputation. The admitted frailty literature supports systematic assessment and shows clinically important associations, but it does not justify a universal cut-off that decides every vascular operation Frailty score outcomes 2023. Each service should therefore be explicit: which frailty measure is recorded, where it is recorded, who acts on it, and whether it is being used to estimate operative risk, discharge needs, likelihood of functional recovery, or tolerance of a complication.

Frailty changes three linked decisions. The first is procedural burden. A technically feasible bypass, aneurysm repair, or reconstruction may be the wrong operation if the physiologic stress, wound burden, surveillance requirement, or rehabilitation demand exceeds the benefit the patient is likely to experience. Conversely, a limited endovascular procedure, minor amputation, staged wound strategy, or carefully selected open operation may be highly appropriate when it targets pain control, sepsis control, walking, or discharge in a way the patient values. The second decision is support. Frailty should trigger early discussion with anesthesia and perioperative medicine where available, medication review, nutrition and mobility planning when relevant, delirium-risk awareness, caregiver planning, and realistic discharge destination. These are practical implications of reduced reserve; they should be described as support needs rather than as frailty-specific interventions proven to erase risk. The third decision is recovery design. Follow-up interval, wound checks, return-to-hospital threshold, rehabilitation route, and caregiver role should be planned before the incision, because frail patients may lose the benefit of a technically successful procedure if the recovery system is improvised.

Chronic limb-threatening ischemia is where frailty most often clarifies the conversation. The team should ask whether limb salvage is a pathway the patient can complete, not merely whether revascularization is anatomically possible. A frail patient with a limited wound, severe rest pain, and strong preference for limb preservation may reasonably undergo a limited or staged strategy if the wound-care and surveillance plan is credible. Another frail patient with extensive tissue loss, infection, severe functional dependence, and little chance of completing months of wound care may be better served by an amputation pathway designed around pain control, infection control, sitting balance, transfers, healing, and discharge. Frailty should make both options more honest. It should not be used to withhold limb salvage reflexively, and it should not be ignored while the patient is enrolled in a reconstruction course they cannot survive or complete Frailty score outcomes 2023 · Association Frailty Failure 2018.

The safest phrasing is explicit and patient-centred. State the intended benefit, the expected burden, the main recovery requirement, the complication that would be hardest for this patient to withstand, and the support that will make the plan possible. This protects against therapeutic nihilism on one side and technical enthusiasm without recovery realism on the other. Frailty is not the answer to the vascular decision. It is the prompt to ask whether the chosen operation, discharge plan, and follow-up pathway match the patient’s reserve and goals.

70.3PAD presentation does not default to one picture

PAD is missed when the clinician waits for the disease to introduce itself as classical claudication. Exertional calf pain relieved by rest remains an important presentation, but it is not the only diagnostic doorway. Contemporary PAD literature describes sex and gender differences across risk exposure, symptom recognition, diagnostic timing, treatment intensity, and outcomes; those differences are clinically important because a narrow claudication script can delay testing, prevention, referral, and revascularization discussion in patients whose limitation is described differently PAD 2024 · PAD 2022. The decision that changes is suspicion: the clinician should keep PAD in play when function, tissue status, pulses, risk burden, or diabetes-related foot risk makes arterial disease plausible, even if the story is not the textbook one.

The diagnostic adjustment is concrete. Ask what the patient no longer does, not only whether a named pain occurs after a named distance. A patient may report slowed pace, reduced confidence walking, fatigue, hip or thigh discomfort, avoidance of activity, exertional leg symptoms that are not described as pain, rest discomfort, or progressive tissue loss. Examination should include pulse assessment and limb inspection; the history should include wounds, diabetes-related foot risk, prior vascular disease, smoking and other cardiovascular risk, medication use, and functional limitation. Current ACC/AHA and ESC PAD guidance supports a broad approach to diagnosis, risk reduction, symptom assessment, function, limb status, revascularization selection, and longitudinal care rather than a single presentation-based algorithm ACC/AHA 2024 · ESC 2024.

Sex and gender context also changes treatment quality after diagnosis. Under-recognition can lead to delayed secondary prevention, less timely referral, and inconsistent discussion of revascularization when symptoms or limb threat justify it PAD 2024 · PAD 2022. Equity literature in PAD adds the same operational warning: disparities in diagnosis, prevention, specialist access, and treatment intensity can shape who reaches care before tissue loss and who receives a durable limb-preservation pathway AHA 2023. The response is not a separate treatment algorithm for every subgroup. It is disciplined application of core vascular care: objective assessment when PAD is plausible, aggressive cardiovascular risk reduction, exercise therapy where available and realistic, revascularization when symptom burden or limb threat warrants it, and follow-up that the patient can actually attend ACC/AHA 2024 · ESC 2024.

Guideline-concordant PAD care still fails if the implementation assumes resources that are absent. A supervised exercise recommendation may be correct but unavailable locally or inaccessible because of transport, work, caregiving, or cost. A prescription list may be complete but not affordable. A wound may require close reassessment, but the patient may not have a reachable wound-care service. A revascularization may be technically successful, but the limb may still fail if surveillance and wound care are not coordinated. PAD guidance should therefore be translated into an access-aware plan: who will arrange testing, who will manage risk reduction, where exercise or walking support will occur, how wounds will be followed, and when vascular reassessment is triggered ACC/AHA 2024 · ESC 2024 · AHA 2023.

For trainees, the bedside rule is simple: a non-classical story should not end the PAD evaluation. It should broaden it. Document function, tissue status, pulses, perfusion testing plan, diabetes-related foot risk, cardiovascular prevention, symptom goals, and the follow-up route. The disease should be allowed to present through the patient’s life and limb, not only through the clinician’s preferred vignette.

70.4Pregnancy and aortopathy need a planned arc of care

Pregnancy-relevant vascular care is safest when the team has made the plan before the urgent question appears. The arc begins before pregnancy when possible, continues through pregnancy and delivery, and extends into the postpartum period. This matters most when the patient has known or suspected aortopathy, prior vascular reconstruction, anticoagulation needs, fetotoxic or pregnancy-sensitive medications, or vascular disease that requires imaging during pregnancy. The plan should name counseling, medication review, imaging strategy, delivery setting, team responsibility, contingency triggers, and postpartum reassessment rather than relying on improvised decisions after pregnancy is established AHA 2022 · ESC 2018 · Obstetric considerations aortopathy 2023.

Pre-pregnancy counseling should define the vascular diagnosis, prior operations, current medication, symptoms, family history where relevant, imaging status, and what would change if pregnancy occurred. The purpose is not simply to warn the patient. It is to make decisions early enough for maternal-fetal medicine, cardiology, anesthesia, genetics when appropriate, haematology when anticoagulation is central, and vascular surgery to agree on surveillance and delivery planning. Medication review belongs at the same visit because therapies that are suitable outside pregnancy may need replacement before conception or prompt adjustment when pregnancy is recognised ESC 2018. Imaging planning also belongs early: the team should know which studies are essential, which can be deferred, which modality is preferred during pregnancy, and how symptoms or interval change will trigger reassessment Obstetric considerations aortopathy 2023.

Aortopathy is the clearest example. Risk assessment must extend beyond the current aortic diameter to include the underlying diagnosis, aortic trajectory, symptoms, family history, prior repair, body-size context, pregnancy timing, and postpartum period. Pregnancy guidance, obstetric-aortopathy synthesis, and contemporary aortic guidance all support coordinated care in which the delivery venue, monitoring plan, and response to aortic symptoms are defined in advance for patients at meaningful risk AHA 2022 · ESC 2018 · Obstetric considerations aortopathy 2023. The postpartum phase should be written into the plan rather than assumed, because risk and surveillance needs may persist after delivery depending on the diagnosis and aortic behavior.

Female-context aortic counseling requires specificity without false precision. Current literature supports discussing pregnancy, heritable aortopathy, body-size considerations, sex context, prior repair, and postpartum risk when they are relevant to the patient’s diagnosis AHA 2022 · Female-Specific Considerations Aortic 2024. What should be avoided is converting that context into a universal female-specific repair diameter or a single postpartum surveillance window across all aortopathies. Thresholds and follow-up intervals remain diagnosis-specific and source-bounded. The record should state which diagnosis is being managed, which framework is being used, what is known about the patient’s trajectory, and what change would prompt escalation ESC 2024.

The same planned-arc logic applies beyond inherited or thoracic aortic disease. A patient with prior vascular reconstruction may need a surveillance and symptom-escalation plan during pregnancy. A patient requiring anticoagulation needs coordinated medication decisions and delivery planning. A patient whose vascular diagnosis requires repeated imaging needs a pathway that balances diagnostic accuracy and pregnancy safety. The practical endpoint is a written plan that the patient and team can follow: what is being monitored, which symptoms require urgent assessment, where delivery should occur, who is responsible for vascular input, and what postpartum reassessment is required AHA 2022 · ESC 2018.

70.5Structural determinants change which follow-up is real

A vascular plan is only as durable as the system that delivers it. Structural determinants influence who is diagnosed early, who reaches vascular care before tissue loss, who receives secondary prevention, who attends wound assessment, and who ultimately undergoes major amputation. Contemporary literature on lower-extremity amputation, PAD disparities, and cardiovascular health equity frames these forces as modifiers of presentation timing, treatment intensity, follow-up access, and outcome rather than as background social description AHA 2023 · PAD 2026 · Social Structural Determinants 2025. The decision that changes is follow-up feasibility: transport, medication affordability, wound-care continuity, referral delay, clinic access, trust, work constraints, and revascularization throughput must be treated as part of vascular risk management.

The aim is not to turn structural context into a blame score for the individual patient. The aim is to identify the fragile steps in the care pathway AHA 2023. If a patient cannot return for weekly wound assessment, a discharge plan that depends on weekly wound assessment is incomplete. If medication cost prevents secondary prevention, the prescription is not yet treatment. If transport barriers delay vascular assessment until tissue loss is advanced, the access problem is part of the limb-risk pathway. If revascularization is performed without a feasible wound-care and surveillance route, the procedure is being asked to succeed without the conditions that make success likely PAD 2026 · Social Structural Determinants 2025.

The operative and discharge plan should therefore use actionable language. “Follow up in clinic” should become a scheduled appointment, a transport plan where needed, and a route for earlier review if the wound deteriorates. “Continue wound care” should identify who will provide it and when the first post-discharge assessment occurs. “Take secondary prevention” should include medication access, simplification when appropriate, and communication with the clinician who will maintain the regimen. “Return if worse” should identify the symptoms or wound changes that matter and the pathway back into vascular reassessment. These steps are operational recommendations drawn from the access problem itself; they should be framed as ways to make evidence-based PAD and limb-preservation care deliverable, not as interventions guaranteed to eliminate disparities ACC/AHA 2024 · ESC 2024 · AHA 2023.

For limb preservation, equity-aware planning often determines whether a technically correct recommendation becomes a real pathway. A patient with diabetes, tissue loss, and interrupted follow-up may need a shorter interval to assessment, a named wound-care route, direct communication with primary care or podiatry, and a low threshold for vascular reassessment. A patient with PAD symptoms and poor access to testing may need diagnostic assessment actively arranged rather than suggested. A patient after revascularization may need surveillance scheduled before discharge and explained in terms that connect patency, wound healing, and limb risk. These measures do not replace guideline-based PAD care; they define the circumstances in which guideline-based care can function ACC/AHA 2024 · ESC 2024 · AHA 2023.

Language matters because vague labels hide remediable system failures. Missed visits, delayed presentation, incomplete medication use, and interrupted wound care often reflect access, affordability, transport, housing, work constraints, prior experiences of care, or fragmented services. The plan should distinguish what the patient is being asked to do from what the system must make possible. That distinction turns an unhelpful concern about adherence into specific tasks: confirm follow-up, coordinate wound care, simplify medication, arrange a route for reassessment, communicate directly with the next clinician, and lower the threshold for review when tissue loss is progressing.

The final test is whether the plan can be carried out without hidden assumptions. If it depends on a clinic the patient cannot reach, dressings the patient cannot obtain, medication the patient cannot afford, or surveillance the system will not schedule, then the vascular plan is not complete. Structural determinants belong inside the operation and follow-up decision because they change which care is real.